Galera Therapeutics, Inc. (GRTX) stock declined over -1.52% intraday to trade at $1.30 a share on NASDAQ. The stock opened with a loss of -12.16% at $1.4 and touched an intraday high of $1.39, falling -1.52% against the last close of $1.32. The stock went to a low of $1.26 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and in Phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy. It is also involved in developing GC4711, a superoxide dismutase mimetic product candidate, which is in Phase I/II clinical trial in combination with stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Galera Therapeutics, Inc. (NASDAQ: GRTX) stock price is $1.3 as of the last check on Thursday, June 30. During the trading session, GRTX stock reached the peak price of $1.39 while $1.26 was the lowest point it dropped to.
The NASDAQ listed GRTX is part of Biotechnology industry that operates in the broader Health Care sector. Galera Therapeutics, Inc. , a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer.
Mr. Christopher Degnan
CFO & Sec.
Mr. Joel F. Sussman
Chief Accounting Officer & Treasurer
Dr. Dennis P. Riley Ph.D.
Chief Scientific Officer
Mr. Arthur J. Fratamico
Chief Bus. Officer
GRTX stock traded closed the last session at $1.3, which is $-0.02 or -1.52% lower than its previous close of $1.32. GRTX's current trading price is 13.04% lower than its 52-week high of $10.79 where as its distance from 52-week low of 1.15% is -87.95%.
Number of GRTX employees currently stands at -. GRTX operates from 2 West Liberty Boulevard, Suite 100, Malvern, PA 19355, United States.
Official Webiste of $GRTX is: https://www.galeratx.com
GRTX stock volume for the day was 84,929 shares while in the previous session number of GRTX shares traded was 84,889 . The average number of GRTX shares traded daily for last 3 months was 144.81 Thousands.
The percentage change in GRTX stock occurred in the recent session was -1.52% while the dollar amount for the price change in GRTX stock was $-0.02.
In the recent session, the day high for GRTX stock was $1.39 while the low for GRTX stock touched on the day was $1.26.
The market value of GRTX currently stands at 31.47 Million with its latest stock price at $1.3 and 26.75 Million of its shares outstanding.